Ikena Oncology Stock Technical Analysis
| IKNA Stock | USD 1.29 0.06 4.44% |
As of the 25th of April, Ikena Oncology retains the Market Risk Adjusted Performance of (0.10), standard deviation of 4.54, and Risk Adjusted Performance of (0.02). Ikena Oncology technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate thirteen technical drivers for Ikena Oncology, which can be compared to its competitors. Please check out Ikena Oncology variance, as well as the relationship between the maximum drawdown and skewness to decide if Ikena Oncology is priced fairly, providing market reflects its last-minute price of 1.29 per share. Given that Ikena Oncology is a hitting penny stock territory we urge to closely look at its jensen alpha.
Ikena Oncology Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Ikena, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IkenaIkena |
Ikena Oncology Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 17.0 | Strong Buy | 5 | Odds |
Most Ikena analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Ikena stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Ikena Oncology, talking to its executives and customers, or listening to Ikena conference calls.
Ikena Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Ikena Oncology Technical Analysis
The output start index for this execution was five with a total number of output elements of fifty-six. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Ikena Oncology volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Ikena Oncology Trend Analysis
Use this graph to draw trend lines for Ikena Oncology. You can use it to identify possible trend reversals for Ikena Oncology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Ikena Oncology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Ikena Oncology Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Ikena Oncology applied against its price change over selected period. The best fit line has a slop of 0.0014 , which may suggest that Ikena Oncology market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.07, which is the sum of squared deviations for the predicted Ikena Oncology price change compared to its average price change.About Ikena Oncology Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Ikena Oncology on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Ikena Oncology based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Ikena Oncology price pattern first instead of the macroeconomic environment surrounding Ikena Oncology. By analyzing Ikena Oncology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Ikena Oncology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Ikena Oncology specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 8.7 | 7.44 | 12.58 | 13.21 | Net Debt To EBITDA | 6.7 | 0.77 | 1.47 | 2.82 |
Ikena Oncology April 25, 2024 Technical Indicators
Most technical analysis of Ikena help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Ikena from various momentum indicators to cycle indicators. When you analyze Ikena charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.10) | |||
| Mean Deviation | 3.12 | |||
| Coefficient Of Variation | (2,298) | |||
| Standard Deviation | 4.54 | |||
| Variance | 20.6 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | (0.11) | |||
| Maximum Drawdown | 23.04 | |||
| Value At Risk | (7.30) | |||
| Potential Upside | 7.53 | |||
| Skewness | 0.8052 | |||
| Kurtosis | 2.16 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ikena Oncology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Ikena Stock refer to our How to Trade Ikena Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Ikena Stock analysis
When running Ikena Oncology's price analysis, check to measure Ikena Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ikena Oncology is operating at the current time. Most of Ikena Oncology's value examination focuses on studying past and present price action to predict the probability of Ikena Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ikena Oncology's price. Additionally, you may evaluate how the addition of Ikena Oncology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Ikena Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ikena Oncology. If investors know Ikena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ikena Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.63) | Revenue Per Share 0.219 | Quarterly Revenue Growth (0.88) | Return On Assets (0.26) | Return On Equity (0.43) |
The market value of Ikena Oncology is measured differently than its book value, which is the value of Ikena that is recorded on the company's balance sheet. Investors also form their own opinion of Ikena Oncology's value that differs from its market value or its book value, called intrinsic value, which is Ikena Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ikena Oncology's market value can be influenced by many factors that don't directly affect Ikena Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ikena Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ikena Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ikena Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.